4Filing Date: Dec 30, 2025
Gilead (GILD) 4: O'Day Daniel Patrick sold 10,000 shares of Common Stock at… (Dec 30, 2025)
Statement of Changes in Beneficial Ownership
View SEC Filing
ACC: 0001638643-25-000017
Total Value$1.25M
Trades1
Insiders1
Transaction Details
O'Day Daniel Patrick
Chairman & CEO, Director·Direct
Sell · Dispose
Common Stock
Shares-10.00K
Price$124.83
Total Value$1.25M
Shares Owned After566.70K
Transaction DateDec 29, 2025
10b5-1
Footnotes ▸
The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025. | Sale prices for the transactions reported range from $124.40 to $125.16. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
Post-Transaction Holdings
O'Day Daniel Patrick · Chairman & CEO, Director
| Security | Shares | Change |
|---|---|---|
| Common Stock | 566.70K | -10.00K (-1.73%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2025-12-29
10b5-1 Pre-arranged Plan: Yes
--- Issuer ---
Name: GILEAD SCIENCES, INC. (GILD)
CIK: 0000882095
--- Reporting Owner ---
Name: O'Day Daniel Patrick
CIK: 0001638643
Role: Director, Officer (Chairman & CEO)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2025-12-29 | Code: S (Open market sale)
Shares: -10,000 | Price: $124.83
Total Value: $1,248,272.00
Shares Owned After: 566,698 | Ownership: D (Direct)
Footnotes:
[F1] The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025.
[F2] Sale prices for the transactions reported range from $124.40 to $125.16. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
--- Footnotes (Complete Index) ---
F1: The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025.
F2: Sale prices for the transactions reported range from $124.40 to $125.16. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
--- Signature ---
/s/ /s/ Edward S. Son by Power of Attorney for Daniel P. O'Day (2025-12-30)